Krystal Biotech Inc (KRYS)
177.41
-6.81
(-3.70%)
USD |
NASDAQ |
Nov 14, 16:00
177.41
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Cash from Operations (Quarterly): 58.86M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 58.86M |
| June 30, 2024 | -4.168M |
| March 31, 2024 | 15.89M |
| December 31, 2023 | -7.232M |
| September 30, 2023 | -21.23M |
| June 30, 2023 | -34.19M |
| March 31, 2023 | -26.16M |
| December 31, 2022 | -22.33M |
| September 30, 2022 | -19.69M |
| June 30, 2022 | -43.06M |
| March 31, 2022 | -15.49M |
| December 31, 2021 | -20.90M |
| September 30, 2021 | -7.255M |
| June 30, 2021 | -10.13M |
| March 31, 2021 | -9.654M |
| December 31, 2020 | -8.024M |
| Date | Value |
|---|---|
| September 30, 2020 | -6.778M |
| June 30, 2020 | -5.054M |
| March 31, 2020 | -6.227M |
| December 31, 2019 | -7.00M |
| September 30, 2019 | -4.266M |
| June 30, 2019 | -4.209M |
| March 31, 2019 | -3.215M |
| December 31, 2018 | -3.518M |
| September 30, 2018 | -1.94M |
| June 30, 2018 | -1.618M |
| March 31, 2018 | -2.369M |
| December 31, 2017 | -2.127M |
| September 30, 2017 | -1.098M |
| June 30, 2017 | -0.408M |
| March 31, 2017 | -0.257M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-43.06M
Minimum
Jun 2022
58.86M
Maximum
Sep 2024
-9.991M
Average
-8.839M
Median
Cash from Operations (Quarterly) Benchmarks
| Bioventus Inc | 10.32M |
| ADMA Biologics Inc | 25.03M |
| Alnylam Pharmaceuticals Inc | 43.71M |
| Amicus Therapeutics Inc | -22.97M |
| Apellis Pharmaceuticals Inc | 34.10M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -34.33M |
| Cash from Financing (Quarterly) | 3.365M |
| Free Cash Flow | 58.06M |
| Free Cash Flow Per Share (Quarterly) | 1.933 |
| Free Cash Flow to Equity (Quarterly) | 57.81M |
| Free Cash Flow to Firm (Quarterly) | 57.81M |
| Free Cash Flow Yield | 1.11% |